OAKLAND

,

Calif.

,

Sept. 27, 2021

/PRNewswire/ –


Harborside Inc.


(“Harborside” or the “Company”) (CSE: HBOR) (OTCQX: HBORF) a

California

-focused, vertically integrated cannabis enterprise, today announced that, subject to shareholder approval, it intends to amend its articles (the “Amendment”) to remove conversion restrictions placed on the Company’s multiple voting shares (“MVS”). The Company anticipates that this change will eventually result in more than 50% of the Company’s issued and outstanding subordinate voting shares (“SVS”) being directly or indirectly owned by shareholders of record domiciled in

the United States

(“U.S.”), which will have the effect of the Company no longer meeting the definition of “foreign private issuer” under U.S. securities laws and the Company will be required to register under the Securities Exchange Act of 1934, as amended (the “Transition”).

If and when the Transition is completed, the Company will be subject to the U.S. Securities and Exchange Commission’s (“SEC”) reporting requirements applicable to U.S. domestic companies. The SEC’s reporting requirements will require, among other things, Harborside’s financial statements and financial data to be presented under U.S. GAAP. The Company expects to seek shareholder approval for the Amendment by the end of the 2021 calendar year and has established a task force of internal and external resources to manage the Transition.

Although the Company will become a U.S. registrant with the SEC, it will continue to be an Ontario corporation. Harborside’s shareholders will not be required to take any action as a result of the Company’s Transition, if and when the Transition is approved and completed, other than officers, directors, and holders of 5% or more of the Company’s shares of SVS. Harborside’s SVS will continue to be listed on the Canadian Securities Exchange (“CSE”) under the symbol “HBOR” and on the OTCQX Best Market under the symbol “HBORF”.

For the latest news, activities, and media coverage, please visit the Harborside corporate website at

www.investharborside.com

or connect with us on


LinkedIn


, and


Twitter


.

About Harborside:

Harborside Inc. is one of the oldest and most respected cannabis retailers in

California

, operating three of the major dispensaries in the

San Francisco Bay Area

, a dispensary in the

Palm Springs

area outfitted with

Southern California’s

only cannabis drive-thru window, a dispensary in

Oregon

and a cultivation/production facility in

Salinas, California

. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of

California

consumers since 2006, when it was awarded one of the first six medical cannabis licenses granted in the United States.  Today, the Company holds cannabis licenses for retail, distribution, cultivation, nursery, and manufacturing. Harborside is a publicly listed company on the CSE trading under the ticker symbol “HBOR” and on the OTCQX Best Market under the ticker symbol “HBORF”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at

www.sedar.com

.

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian and

United States

securities legislation. To the extent any forward-looking information in this news release constitutes “financial outlooks” or “future-oriented financial information” within the meaning of applicable Canadian securities laws, the reader is cautioned not to place undue reliance on such information. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to the implementation of the Amendment, shareholder approval to be sought for the Amendment, changes that will result in more than 50% of the Company’s issued and outstanding SVS being directly or indirectly owned by shareholders of record domiciled in the U.S., completion of the Transition, and implications of the completion of the Transition.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: implications of the COVID-19 pandemic on the Company’s operations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political, social and environmental uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations; the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates; and the risk factors set out in the Company’s management’s discussion and analysis for the quarter ended

June 30, 2021

and the Company’s listing statement dated

May 30, 2019

, which are available under the Company’s profile on

www.sedar.com

. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company, through several of its subsidiaries, is indirectly involved in the manufacture, possession, use, sale, and distribution of cannabis in the recreational and medicinal cannabis marketplace in

the United States

. Local state laws where the Company operates permit such activities however, investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in

the United States

. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in

the United States

to, among other things, cultivate, distribute or possess cannabis in

the United States

. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in

the United States

may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in

the United States

has trended toward non-enforcement against individuals and businesses that comply with recreational and medicinal cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under US federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. The enforcement of federal laws in

the United States

is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect the Company’s operations and financial performance.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in

the United States of America

. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”) or any state securities laws and may not be offered or sold within

the United States

or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:

https://www.prnewswire.com/news-releases/harborside-expected-to-transition-to-domestic-issuer-status-in-united-states-301385525.html

SOURCE Harborside Inc.